Affiliate-supportedIndependent editorialWe never sell medicationSee how
M. in TX switched Ozempic → compounded semaglutide — $8,160/year
2 min ago · illustrative aggregate
Third-party reviews
Aggregate snapshot. Verify current scores via the linked profiles.
Short answer: yes — Hims is a legitimate FDA-brand telehealth provider (our editorial score: 8.4/10). Below are the legitimacy signals we verified, plus the honest caveats. GLP1Zoom earns a commission if you sign up via our link — but we don't sell anything ourselves and assess every provider the same way.
Licensed US telehealth
Hims operates as a licensed telehealth platform connecting patients to US-licensed prescribers.
FDA-approved brand medications
Hims prescribes FDA-approved brand medications with full regulatory oversight.
Established operating history
Founded 2017 — 9 years operating.
Transparent pricing
Publishes starting price ($99/mo) — no hidden-cost surprises at signup.
Still comparing? See Hims alternatives or our ranked best-GLP-1-telehealth list.
Our independent assessment of what Hims discloses vs hides before signup. Updated quarterly.
Per-drug price card grid upfront
"From $149/mo†" anchor visible on every drug card on landing
Named medical lead: Dr. Craig Primack
Obesity medicine MD with photo + credentials
FDA + off-label disclosures inline
Explicit "not affiliated with Eli Lilly" + Wegovy/Zepbound/Foundayo FDA-approval labels
$39 first month, $149 auto-renew
Trial-anchor pricing surfaced openly but still trial-anchor pattern
Quiz-gated specific medication choice
"$149 if prescribed" — actual drug determined only after quiz
Transparency does not equal medical quality. A provider can have hidden pricing but excellent clinical care, and vice versa. This callout reflects only what we can independently verify from public materials, not a recommendation.
Starting price
$99/mo
Consultation
$0
Insurance
No
Shipping
5d
brand
$299–$399/mo
Considering a switch from Hims?
Compare alternative telehealth providers — pricing, drug menu, FDA-brand vs compounded.
Yes — Hims is a legitimate FDA-brand telehealth provider connecting patients to US-licensed prescribers, operating since 2017. It dispenses FDA-approved brand medications with full regulatory oversight.
Hims prescribes GLP-1 medications (brand semaglutide/tirzepatide) whose efficacy is well-established — semaglutide ~15% and tirzepatide ~22% average body-weight loss in trials. Results depend on the medication, dose adherence, and lifestyle, not the telehealth platform itself. Hims provides the prescription + delivery; the drug does the work.
Hims starts at $99/month. Final cost depends on medication, dose, and whether consultation/shipping are bundled. Verify current pricing on the Hims website.
Hims is worth considering if you prioritize FDA-brand medications with full regulatory oversight. Compare it against alternatives before deciding — see our Hims alternatives page.
Hims typically ships in about 5 days after prescription approval. GLP-1 medications arrive in insulated cold-chain packaging.
Depending on your priority — lower cost, FDA-brand, female-focused care, or insurance support — several telehealth providers compete with Hims. See our Hims alternatives page for a ranked comparison.
Information only — not medical advice. GLP1Zoom sells nothing; all transactions are between you and the third-party provider. Why.
30-second filter
Pick one. We'll line up the partners and FDA-approved options that match your priority. (Not medical screening — preference filter only.)